Protection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors

scientific article published on 30 October 2007

Protection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1440-1681.2007.04819.X
P698PubMed publication ID17973934
P5875ResearchGate publication ID5872289

P2093author name stringHui Wang
Dan Xu
Yu Guo
Liao-Bin Chen
Jie Ping
Ben-Jian Zhang
P2860cites workEffects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in ratsQ33246062
Acetaldehyde-mediated collagen regulation in hepatic stellate cellsQ33661177
Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injuryQ33822590
Molecular mechanism of the reversibility of hepatic fibrosis: with special reference to the role of matrix metalloproteinases.Q33888050
Pathogenesis of liver fibrosis: role of oxidative stressQ34025940
Oxidative stress, plant-derived antioxidants and liver fibrosisQ34623869
Liver fibrosis -- from bench to bedsideQ35068035
Hepatic fibrosis: molecular mechanisms and drug targetsQ35911848
Connective tissue biology and hepatic fibrosis: report of a conferenceQ37905957
Expression of Smads during in vitro transdifferentiation of hepatic stellate cells to myofibroblastsQ38301076
PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cellsQ40225700
Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2.Q40334903
Stimulation of collagen alpha 1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis?Q42285597
Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte.Q42832329
The role of Smad3 in mediating mouse hepatic stellate cell activationQ43657688
Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat liversQ43878352
Inhibitory effect of berberine on tert-butyl hydroperoxide-induced oxidative damage in rat liverQ44204335
The role of TGFbeta1 in initiating hepatic stellate cell activation in vivoQ44383140
Regulation of collagen synthesis by ascorbic acid: characterization of the role of ascorbate-stimulated lipid peroxidationQ44969392
Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF.Q46802333
Inhibitory effects of Zoagumhwan water extract and berberine on angiotensin II-induced monocyte chemoattractant protein (MCP)-1 expression and monocyte adhesion to endothelial cellsQ47769851
Toxicity of hepatotoxins: new insights into mechanisms and therapy.Q53668234
P433issue3
P921main subjecthepatotoxicityQ1349821
P304page(s)303-309
P577publication date2007-10-30
P1433published inClinical and Experimental Pharmacology and PhysiologyQ5133807
P1476titleProtection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors
P478volume35

Reverse relations

cites work (P2860)
Q389669928-Hydroxy-2'-deoxyguanosine as a biomarker of oxidative DNA damage induced by perfluorinated compounds in TK6 cells.
Q34494504A comparative study on the hepatoprotective action of bear bile and Coptidis Rhizoma aqueous extract on experimental liver fibrosis in rats
Q47723208Addition of Berberine to Preservation Solution in an Animal Model of Ex Vivo Liver Transplant Preserves Mitochondrial Function and Bioenergetics from the Damage Induced by Ischemia/Reperfusion
Q26745650Anti-fibro-hepatocarcinogenic Chinese herbal medicines: A mechanistic overview
Q36901429Berberine Inhibition of Fibrogenesis in a Rat Model of Liver Fibrosis and in Hepatic Stellate Cells
Q57051612Berberine attenuate staphylococcal enterotoxin B-mediated acute liver injury via regulating HDAC expression
Q55052225Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy.
Q38928488Berberis Vulgaris and Berberine: An Update Review
Q33819605Berberis vulgaris and its constituent berberine as antidotes and protective agents against natural or chemical toxicities
Q33724172Berberis vulgaris extract/β-cyclodextrin complex increases protection of hepatic cells via suppression of apoptosis and lipogenesis pathways.
Q38848565Bi-content micro-collagen chip provides contractility-based biomechanical readout for phenotypic drug screening with expanded and profiled targets
Q64102549Chinese Herbal Medicine for Wilson's Disease: A Systematic Review and Meta-Analysis
Q35575460Chinese medicines as a resource for liver fibrosis treatment
Q26775055Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects
Q87279784Effects of isoquinoline alkaloid berberine on lipid peroxidation, antioxidant defense system, and liver damage induced by lead acetate in rats
Q42519490Fat mass and obesity-associated gene enhances oxidative stress and lipogenesis in nonalcoholic fatty liver disease
Q35131516Fucoidan from Fucus vesiculosus protects against alcohol-induced liver damage by modulating inflammatory mediators in mice and HepG2 cells
Q39342467Hepatoprotection of berberine against hydrogen peroxide-induced apoptosis by upregulation of Sirtuin 1.
Q42795444Hepatoprotective activity of berberine is mediated by inhibition of TNF-α, COX-2, and iNOS expression in CCl4-intoxicated mice
Q38744898Integrative analysis of signaling pathways and diseases associated with the miR-106b/25 cluster and their function study in berberine-induced multiple myeloma cells
Q52668163Metformin and berberine, two versatile drugs in treatment of common metabolic diseases.
Q51284373PASS-predicted hepatoprotective activity of Caesalpinia sappan in thioacetamide-induced liver fibrosis in rats.
Q36175416Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control
Q36357775Preventive effects of phenylethanol glycosides from Cistanche tubulosa on bovine serum albumin-induced hepatic fibrosis in rats
Q37210162Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice
Q38326327Protective mechanisms of medicinal plants targeting hepatic stellate cell activation and extracellular matrix deposition in liver fibrosis
Q42158636Resolution of liver fibrosis by isoquinoline alkaloid berberine in CCl₄-intoxicated mice is mediated by suppression of oxidative stress and upregulation of MMP-2 expression
Q42176100Role of berberine in ameliorating Schistosoma mansoni-induced hepatic injury in mice
Q37587875Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies.
Q42723826The protective role of natural phytoalexin resveratrol on inflammation, fibrosis and regeneration in cholestatic liver injury
Q36988577Update on berberine in nonalcoholic Fatty liver disease

Search more.